Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.
作者信息
Jarvis Joseph N, Meintjes Graeme, Harrison Thomas S
出版信息
J Infect. 2010 Jun;60(6):496-8. doi: 10.1016/j.jinf.2010.03.007. Epub 2010 Mar 20.
Abstract
摘要
相似文献
1
Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.南非未接受过抗逆转录病毒治疗和有抗逆转录病毒治疗经验的患者的隐球菌性脑膜炎转归
J Infect. 2010 Jun;60(6):496-8. doi: 10.1016/j.jinf.2010.03.007. Epub 2010 Mar 20.
2
Cryptococcal Meningitis Presenting as a Complication in HIV-infected Children: A Case Series From Sub-Saharan Africa.隐球菌性脑膜炎作为艾滋病毒感染儿童的并发症：来自撒哈拉以南非洲的病例系列
Pediatr Infect Dis J. 2016 Sep;35(9):979-80. doi: 10.1097/INF.0000000000001212.
3
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.博茨瓦纳在成功推出抗逆转录病毒疗法后出现的人类免疫缺陷病毒（HIV）晚期疾病：隐球菌性脑膜炎的发病率和时间趋势。
Clin Infect Dis. 2017 Sep 1;65(5):779-786. doi: 10.1093/cid/cix430.
4
Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.比勒陀利亚一家三级医院的隐球菌性脑膜炎、死亡率及危险因素——一项回顾性队列研究
Int J STD AIDS. 2017 Apr;28(5):480-485. doi: 10.1177/0956462416653559. Epub 2016 Jul 10.
5
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.一种管理确诊为HIV相关隐球菌性脑膜炎且有抗逆转录病毒治疗经验患者的实用方法：抗逆转录病毒治疗依从性和疗程的影响
AIDS. 2020 Jul 15;34(9):1425-1428. doi: 10.1097/QAD.0000000000002556.
6
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.在未接受过抗逆转录病毒治疗或有抗逆转录病毒治疗经验的患者中，使用两性霉素B或氟康唑治疗隐球菌性脑膜炎时的真菌负荷、早期杀菌活性及治疗结果。
Clin Infect Dis. 2007 Jul 1;45(1):76-80. doi: 10.1086/518607. Epub 2007 May 25.
7
Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.泰国开始接受抗逆转录病毒治疗的HIV感染女性中隐球菌抗原筛查的效用及无症状隐球菌抗原血症的演变
J Int Assoc Provid AIDS Care. 2014 Sep-Oct;13(5):434-7. doi: 10.1177/2325957413500533. Epub 2013 Sep 3.
8
Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.南非索韦托地区艾滋病毒感染者隐球菌抗原血症的筛查与治疗评估
HIV Med. 2015 Sep;16(8):468-76. doi: 10.1111/hiv.12245. Epub 2015 Feb 17.
9
Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.印度西北部 HIV 感染者无症状隐球菌抗原血症的流行率及其与隐球菌性脑膜炎和死亡率随访风险的相关性：一项前瞻性队列研究。
Curr HIV Res. 2021;19(1):35-39. doi: 10.2174/1570162X18666200827113816.
10
Preventing deaths from cryptococcal meningitis: from bench to bedside.预防隐球菌性脑膜炎死亡：从基础到临床。
Expert Rev Anti Infect Ther. 2011 Sep;9(9):715-7. doi: 10.1586/eri.11.86.
引用本文的文献
1
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.近期开始抗逆转录病毒治疗与HIV相关隐球菌性脑膜炎患者死亡风险增加有关：一项来自非洲的临床试验数据分析
Clin Infect Dis. 2025 Aug 1;81(1):75-83. doi: 10.1093/cid/ciae586.
2
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.一种管理确诊为HIV相关隐球菌性脑膜炎且有抗逆转录病毒治疗经验患者的实用方法：抗逆转录病毒治疗依从性和疗程的影响
AIDS. 2020 Jul 15;34(9):1425-1428. doi: 10.1097/QAD.0000000000002556.
3
Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲地区与 HIV 相关的脑膜炎的死亡率：系统评价和荟萃分析。
J Int AIDS Soc. 2020 Jan;23(1):e25416. doi: 10.1002/jia2.25416.
4
Neurological disorders in HIV in Africa: a review.非洲地区HIV相关神经系统疾病综述
Afr Health Sci. 2019 Jun;19(2):1953-1977. doi: 10.4314/ahs.v19i2.19.
5
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.近期开始抗逆转录病毒治疗后暴露隐球菌性脑膜炎的不良后果。
Open Forum Infect Dis. 2018 May 24;5(8):ofy122. doi: 10.1093/ofid/ofy122. eCollection 2018 Aug.
6
Global HIV neurology: a comprehensive review.全球 HIV 神经科学：全面综述。
AIDS. 2019 Feb 1;33(2):163-184. doi: 10.1097/QAD.0000000000001796.
7
Cryptococcal meningitis: A neglected NTD?隐球菌性脑膜炎：一种被忽视的被忽视热带病？
PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. eCollection 2017 Jun.
8
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.艾滋病相关隐球菌性脑膜炎治疗的最新进展，重点关注资源有限的环境。
Expert Rev Anti Infect Ther. 2017 Apr;15(4):331-340. doi: 10.1080/14787210.2017.1285697. Epub 2017 Feb 9.
9
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.隐球菌性脑膜炎：流行病学、免疫学、诊断与治疗。
Nat Rev Neurol. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25.
10
Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.纳米比亚晚期免疫抑制的艾滋病毒感染成人中隐球菌抗原血症（CrAg）的估计患病率证明了进行常规筛查和预防性治疗的合理性。
PLoS One. 2016 Oct 19;11(10):e0161830. doi: 10.1371/journal.pone.0161830. eCollection 2016.
本文引用的文献
1
Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.南非与 HIV 相关的隐球菌性脑膜炎有症状复发：二级预防不足的作用。
S Afr Med J. 2010 Jun;100(6):378-82. doi: 10.7196/samj.3515.
2
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.感染清除率与HIV相关隐球菌性脑膜炎临床结局之间的独立关联：对262例患者合并队列的分析
Clin Infect Dis. 2009 Sep 1;49(5):702-9. doi: 10.1086/604716.
3
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.尽管抗逆转录病毒疗法已推广，但非洲隐球菌病的持续负担仍然很高。
AIDS. 2009 Jun 1;23(9):1182-3. doi: 10.1097/QAD.0b013e32832be0fc.
4
Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.在南非接受抗逆转录病毒治疗项目的患者中进行隐球菌抗原血症筛查。
Clin Infect Dis. 2009 Apr 1;48(7):856-62. doi: 10.1086/597262.
5
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.对全球感染艾滋病毒/艾滋病者中隐球菌性脑膜炎当前负担的估计。
AIDS. 2009 Feb 20;23(4):525-30. doi: 10.1097/QAD.0b013e328322ffac.
6
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.撒哈拉以南非洲地区接受抗逆转录病毒治疗项目的成年人的早期死亡率。
AIDS. 2008 Oct 1;22(15):1897-908. doi: 10.1097/QAD.0b013e32830007cd.
7
The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana.在博茨瓦纳，使用高效抗逆转录病毒疗法（HAART）与成人隐球菌性脑膜炎初始治疗期间死亡风险降低相关。
J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):227-9. doi: 10.1097/QAI.0b013e318183181e.
8
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.在未接受过抗逆转录病毒治疗或有抗逆转录病毒治疗经验的患者中，使用两性霉素B或氟康唑治疗隐球菌性脑膜炎时的真菌负荷、早期杀菌活性及治疗结果。
Clin Infect Dis. 2007 Jul 1;45(1):76-80. doi: 10.1086/518607. Epub 2007 May 25.
9
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.联合抗逆转录病毒治疗时代艾滋病相关隐球菌病的长期结局
AIDS. 2006 Nov 14;20(17):2183-91. doi: 10.1097/01.aids.0000252060.80704.68.
10
Immune restoration disease after antiretroviral therapy.抗逆转录病毒治疗后的免疫重建疾病
AIDS. 2004 Aug 20;18(12):1615-27. doi: 10.1097/01.aids.0000131375.21070.06.
Zotero 插件